Crealta Report issue

For profit Phase 2 Phase 3
Founded: Lake Forest IL United States (2013)
Status: Acquired by Horizon Pharma (2015) → now Amgen

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

Key: Crealta (0) Acquired (1)

pegloticase (krystexxa) (6 trials)

Drugs in Phase 2 Trials (1)

Key: Crealta (0) Acquired (1)

prosaptide (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 7
  • # of Trial APIs: 2